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Background: Diacylglycerol kinase (DGK) is a key enzyme that regulates diacylglycerol (DG) turnover and is
involved in a variety of physiological functions. The isoform DGKθ has a unique domain structure and is the sole
member of type V DGK. To reveal the spatial and temporal expression of DGKθ we performed
immunohistochemical staining on paraffin sections of mouse embryos.
Results: At an early stage of development (E10.5 and 11.5), the expression of DGKθ was prominently detected in
the brain, spinal cord, dorsal root ganglion, and limb bud, and was also moderately detected in the bulbus cordis
and the primordium of the liver and gut. At later stages (E12.5 and 14.5), DGKθ expression persisted or increased in
the neocortex, epithalamus, hypothalamus, medulla oblongata, and pons. DGKθ was also evident in the epidermis,
and nearly all epithelia of the oropharyngeal membrane, digestive tract, and bronchea. At prenatal developmental
stages (E16.5 and E18.5), the expression pattern of DGKθ was maintained in the central nervous system, intestine,
and kidney, but was attenuated in the differentiated epidermis.
Conclusion: These results suggest that DGKθ may play important physiological roles not only in the brain, but also
in diverse organs and tissues during the embryonic stages.
Keywords: Diacylglycerol kinase, Embryonic development, Central nerve system, EpidermisBackground
Many hormones and growth factors stimulate phospholip-
ase C by activating its receptor. This activation results in
the production of diacylglycerol (DG) at the plasma mem-
brane, which triggers the activation of several enzymes,
such as chimerins [1], Ras guanyl nucleotide-releasing pro-
tein (RasGRPs) [2,3], transient receptor potential cation
channel C (TRPC) [4], and both conventional and novel
PKCs [5,6]. DG kinase (DGK) phosphorylates DG to pro-
duce phosphatidic acid (PA), resulting in the inhibition of
DG-mediated intracellular signal transduction. Additionally,
PA is a lipid second messenger that regulates various target
proteins, including atypical PKC, mTOR, and phos-
phatidylinositol 4-phosphate 5-kinase [7,8]. Thus, DGK
plays pivotal roles in various intracellular signaling path-
ways by regulating the DG and PA levels [9-12]. Ten DGK
isoforms have been identified in mammal, and classified* Correspondence: shirai@kobe-u.ac.jp
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reproduction in any medium, provided the orinto five subtypes, from I to V, based on similarities in the
domain structures.
The physiologic roles of DGK isoforms have been par-
tially elucidated by analyses of DGK gene expression pat-
terns and of genetically modified organisms. For example,
DGKβ is a major isoform expressed in the brain, and the
disruption of this isoform impairs memory and causes
antidepressant-like effects in mice [13]. In contrast, DGKα
enhances interleukin 2-induced T cell proliferation [14],
and knockout (KO) mice exhibit impaired induction of T
cell anergy [15]. Another isoform, DGKζ is a type IV DGK
that is ubiquitously expressed in most mouse tissues. DGKζ
KO mice exhibit abnormalities in multiple tissues, includ-
ing a decrease in the number of dendritic spines, and an
impairment of the immune response [4,16,17]. In regard to
nervous system, a large number of studies have shown the
roles of DGKs in neuronal spine density, synaptic activity,
epileptogenesis and neuronal plasticity in mammals [18,19]
and C. elegans used as a genetic model [20]. It is not clear
the relationships of ten DGK isoforms in mammal. To bet-
ter understand the role of each DGK and its redundancytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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DGKs are necessary.
DGKθ was originally cloned from the rat brain and iden-
tified as the sole type V DGK [21]. DGKθ contains three C1
domains and a Ras-association (RA) domain in the central
region. Studies have shown that DGKθ is enriched in the
nuclear matrix of various cultured cell lines [22], is nega-
tively regulated by its interaction with the small GTPase
RhoA [23], and translocate to the plasma membrane fol-
lowing phosphorylation by PKCε [24]. The optimal activa-
tion of DGKθ may require both polybasic protein and
acidic phospholipid cofactors, which have been shown to
stimulate DGKθ synergistically in vitro [25,26]. These mul-
tiple regulatory mechanisms enable DGKθ to mediate sig-
nals from a wide variety of extracellular ligands [24,27]
including epidermal growth factor [28], nerve growth factor
[29], α-thrombin [30], and adenosine[31].
DGKθ is highly expressed in rat brain [21] and is
present in a variety of cultured cell lines [22,24]. How-
ever, there is limited information regarding this enzyme’s
cell type-specific functions or its physiological roles in
mammals. In this study, we examined the distribution
and changes in expression from E10 to E17 to reveal the
spatial and temporal expression of DGKθ protein in
mouse embryos.
Results
Expression patterns of DGKθ in E10.5 to E16.5 mouse
embryos
To determine the distribution of DGKθ, we performed
immunohistochemistry (IHC) on paraffin sections of
mouse embryos. We used two individual antibodies that
target the C-terminal region of the protein, anti-DGKθ
antibodies #1 and #2, to validate immunostaining pat-
terns. Both antibodies detected a major 110-kDa band of
DGKθ on an immunoblotting membrane containing the
extract from whole brain (Additional file 1: Figure S1 C),
in which DGKθ had been detected with RT-PCR (data
not shown). The observed molecular size coincided with
the size of endogenous protein (110 kDa) in HEK293
and HeLa cell lysates by immunoblotting [16,23]. The
specificity of this antibody was further confirmed by the
transient transfection. These antibodies successfully
detected exogenously expressed recombinant DGKθ
protein by immunofluorescence in HeLa cells, but not
other subtypes (Additional file 2: Figure S2 and data not
shown).
At E10.5, the immunoreactivity of DGKθ was notice-
able along the surface of the forebrain (fb), rhomben-
cephalon (rb), and neural tube (nt) (Figure 1A-C and F),
and was also distinctly observable in the ectodermal epi-
thelium of the hind bud (hb) (Figure 1H) (evident as
brown staining in all images). DGKθ expression was also
detected in the branchial arch (ba), bulbus cordis (bc),hepatic primordium (hp), midgut artery (ma), and notal
cord (nc) (Figure 1A). A similar staining pattern
persisted at E11.5. Immunoreactivity of DGKθ was
detected in the bulbus cordis, liver (li), and lumen of the
stomach and midgut (mg) (Figure 1I and M). In addition
to the distribution observed at E10.5, DGKθ staining
was noted in the tongue (to), nasal placode (np), primi-
tive bronchi (br), the dorsal root ganglion (drg), and the
trachea (tr) separating from the esophagus at E11.5
(Figure 1 I, K and L). It is noteworthy that the immuno-
reactivity significantly increased in the neuroepithelium
surrounding the third ventricle (tv) at E11.5 compared
with that at E10.5 (Figure 1K). In contrast to the faint
staining of the mesenchymal cells around the cephalic
region, the immunoreactivity of the mesenchymal cells
around the peripheries of the tongue (to) and nasal
placode (np) was relatively high (Figure 1A-B and I).
The embryonic brain grows rapidly until E12.5, and the
forebrain partly divides into the telencephalon (t) and di-
encephalon (d). Simultaneously, a pharynx membrane and
respiratory apparatus rapidly develop. In the current study,
at E12.5 the immunoreactivity in the cephalic region in-
creased intensively at the rostral side of the telencephalon,
the tectum of midbrain, and the pontine flexure (pf) in
which neuroepithelial cells proliferate (Figure 2A-C). Fur-
thermore, the immunoreactivity persisted or increased in
multiple organs (tongue, lung, liver, heart, and midgut) (Fig-
ure 2A and D), and expanded to the surface layer of the
nasal cavity and dental lamina (dl) (Figure 2E). A similar
pattern of distribution was observed at E13.5 (data not
shown).
In the developing central nervous system region at E14.5,
DGKθ immunoreactivity was widely distributed in all brain
regions. Particularly dense immunoreactivity was observed
in the neocortex (nx), epithalamus (epi), medulla oblongata
(mo), and the gray horn of spinal cord (Figure 2F-I, K
and N). However, DGKθ was not detected in the ganglionic
eminence (ge), which localizes to the medial side of the lat-
eral ventricle (Figure 2H). In other areas, dense immunore-
activity was continually detected within various types of
epithelia, including the tongue (to), tooth bud (tb), nasal
cavity (nc), bronchus (br), midgut (mg), and urogenital
sinus (us) (Figure 2F, I, J, M, O and P). In contrast to the
immunoreactivity predominantly observed in the epithelia
classified as simple or stratified epithelium, DGKθ protein
was undetectable in the endothelial cells of the arterial
trunk (Figure 2A and F). Beginning at E14.5, the fetal skin
increased in thickness and formed the layer of the squa-
mous epithelium. At the facial and dorsal surfaces we found
a significant increase of immunoreactivity in the squamous
epithelial cells, which successively differentiate into epider-
mis (Figure 2J and N). IHC without the DGKθ antibody
failed to detect any signal in the sections from E10.5 to



























































Figure 1 Expression patterns of DGKθ at E10.5 and E11.5. (A, I) Sagittal sections showing the distribution of DGKθ. (B-H) High magnification
images showing DGKθ-positive regions at E10.5. Forebrain (fb), midbrain (mb), rhombencephalon (rb), third ventricle (tv), cephalic mesenchyme
(cm), branchial arch (ba), atrial chamber (ac), bulbus cordis (bc), notochord (nc), hepatic primordium (hp), midgut artery (ma), hindlimb bud (hb).
(J-Q) High magnification images showing DGKθ positive region at E11.5. Spinal cord (sp), esophagus (ep), nasal placode (np), trachea (tr), tongue
(to), bronchi (br), stomach (st), liver (li), arterial trunk aortic arch (aa), dorsal root ganglion (drg), midgut (mg). The sections were stained with anti-
DGKθ antibody #1. The scale bars show 100 μm.
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embryogenesis
At E16.5, the immunoreactivity of DGKθ was maintained
in the neocortex (nx) and the mesencephalon (Figure 3A),
and increased in the villi (vi) and mucosa (mu) of the intes-
tine (Figure 3C) and the basal layer (bl) of the dorsal skin(ds) (Figure 3D). In contrast, we found that the immunore-
activity of DGKθ was attenuated in the lung (Figure 3B)
and liver at E16.5. At prenatal developmental stages (E17.5
and E18.5), DGKθ immunoreactivity was unchanged in the
brain region relative to the E14.5. In other areas, immuno-







































































Figure 2 Expression patterns of DGKθ at E12.5 and E14.5. (A, F) Sagittal sections showing the distribution of DGKθ. (B-E) High-magnification
images showing DGKθ-positive regions at E12.5. Telencephalon (t), diencephalon (d), midbrain (mb), arterial trunk (at), tongue (to), lung (lu),
dorsal root ganglion (drg), bronchus (br), dental lamina (dl), oral epithelium (oe). (F-P) High-magnification images showing DGKθ-positive regions
at E14.5. Neocortex (nx), lateral ventricle (lv), ganglionic eminence (ge), epithalamus (epi), cerebellum (ce), medulla oblongata (mo), pituitary gland
(pi), pons (po), hypothalamus (hyt), nasal cavity (nc), tooth bud (tb), follicle (f), lung (lu), liver (li), dorsal skin (dr), midgut (mg), mucosa layer (mu),
urogenital sinus (us), kidney (k). The sections were stained with anti-DGKθ antibody #1. The scale bars indicate 100 μm.
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dorsal surfaces (Figure 3H and K), the walls of the tranche
and main bronchus, and the ventricular wall of the heart
(Figure 3I and J), while strong signals persisted in the villi
and mucosa of the intestine (Figure 3M) and in the
collecting tubule (ct) and Bowman’s capsule (bc) of thekidney (Additional file 3: Figure S3 A and D). The intensity
and pattern of the immunoreactivity was also verified by
examining serial sections with two different anti-DGKθ
(antibodies #1 and #2) (Additional file 3: Figure S3 B and
C). When the anti-DGKθ antibody was preincubated with























































Figure 3 Expression patterns of DGKθ at E16.5 and E18.5. (A, E) Sagittal sections showing the distribution of DGKθ. (B-D) High-magnification
images showing discriminative regions at E16.5. Thalamus (tha), neocortex (nx), ganglionic eminence (ge), lung (lu), alveolar duct (ad), intestine
(in), villi (vi), mucosa (mc), dorsal skin (ds), basal layer (bl). (E-M) High magnification images showing discriminative regions at E18.5. cerebellum
(ce), salivary glands (sg), thymus (th), dorsal muscles (dm), diaphragm (di), dorsal root ganglion (drg), pancreas (pa), marginal zone (mz),
ventricular zone (vz), dental pulp (dp), enamel epithelium (ee), follicle (f), muffle (mf), throat (tr), aortic trunk (at), ventricle (v), ventricular wall (vw)
The sections were stained with anti-DGKθ antibody #1. The scale bars indicate 100 μm.
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(pa) and the surface of the villi in the duodenum, which
corresponded with IHC results obtained without the pri-
mary antibody (Additional file 3: Figure S3 D and E).
RT-PCR analysis of DGKθ expression in mouse embryos
To confirm the distribution of DGKθ, we analyzed the ex-
pression of the DGKθ mRNA at E14.5 using semiquantita-
tive RT-PCR. The results demonstrated that DGKθ was
expressed in multiple organs (brain, lung, liver, intestine,
kidney, and dorsal skin) at E14.5. Additionally, DGKθ was
expressed more abundantly in the brain and dorsal skin
than in the other organs (Figure 4A). This expressionprofile of the mRNA is consistent with the immunohisto-
chemical observation, which indicated that DGKθ was dis-
tributed among various epithelia and neurons at E14.5.
To examine the change in DGKθ expression during de-
velopment, we analyzed the expression in dorsal skin from
E14.5 until adulthood. In the developmental skin, the ex-
pression of DGKθ was significantly higher at E14.5 than at
E17.5 and during adulthood (Figure 4A and B).
Discussion
To examine the regional distribution of DGKθ during the
embryonic period, we performed immunohistochemistry












































At E14.5 Dorsal skin
A B
** * *
Figure 4 RT-PCR analysis of DGKθ expression in mouse embryo. The DGKθ mRNA levels were determined by semiquantitative RT-PCR. The
number of amplification cycles for DGKθ and GAPDH were 35 and 28, respectively. The amount of template for each PCR was normalized to the
expression level of GAPDH. (A) Relative expression of DGKθ in diverse organs at E14.5. The values (mean ± SEM, n = 4) represent the relative level
of expression in the whole brain compared with the lung, liver, intestine, or kidney. ** indicates P < 0.01 and * indicates P < 0.05 (B) Relative
expression of DGKθ at each developmental stage in the epidermis of the dorsal skin. The amount of template for each PCR was normalized to
the expression level of GAPDH. The values (mean ± SEM, n = 4) represent the relative level of expression at E14.5. * indicates P < 0.05 compared
with E17.5 or adulthood skin.
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multiple organs and abundantly expressed in the brain and
dorsal skin of mouse embryos. These results were con-
firmed by the analysis of DGKθ mRNA using RT-PCR and
in situ hybridization (Figure 4 and Additional file 1: Figure
S1B). The IHC results demonstrated that the expression of
DGKθ significantly increased in the neuroepithelium sur-
rounding the neural tube and ventricles in the brain. Prom-
inent immunoreactivity of DGKθ was observed in a variety
of neurons in the gestational brain over the period exam-
ined (E10.5-18.5). Especially, DGKθ was detected in the
marginal zone of the neocortex, but not in the medial side
of the lateral ventricle at E14.5 and E16.5. Since developing
mammalian telencephalon is known to require atypical
PKC [32], these results may suggest that DGKθ is associ-
ated with differentiation of the neuronal lineage or the loco-
motion of immature neurons [33]. During the prenatal
period (E18.5), DGKθ was expressed in the developing
cerebral cortex, hippocampus, and cerebellum. This distri-
bution pattern is consistent with the in situ hybridization
data for the adult rat brain [21]. Other DGK isoforms are
known to be expressed in the postnatal brain [34-36] and
are needed for various roles of mature neurons [37-39]. C.
elegans DGK-1, which has 39% identity to mouse DGKθ,
regulates DAG levels generated by heterotrimeric G protein
signaling in response to the neurotransmitters in nematode
[40]. Genetic analysis of C.elegans, dgk-1 shows the role of
dopamine controlled locomotion and serotonin-controlled
egg-laying behavior [41]. The presence of DGKθ through-
out the prenatal brain at E18.5 suggests either that DGKθ isinvolved in a common neuronal process, or that it provides
a level of redundancy for other DGK isoforms in neurons
[29,39].
In the periphery, IHC results revealed that DGKθ is
ubiquitously expressed in the layer of multiple organs
during the embryonic period. In the intestine and kid-
ney, the expression of DGKθ was prominent and
persisted from E12.5 up to E18.5, while DGKθ expres-
sion in the lung, liver, and oropharyngeal membrane sur-
rounding the tongue and nasal cavity was transient and
attenuated before birth. Since DGKθ enhances the acti-
vation of EGF receptor stimulated with EGF via the
counteraction of PKC activity in epidermoid cells [28],
DGKθ may notably contribute to the development of
epithelial cells during organogenesis (E10.5-E17.5). RT-
PCR analysis demonstrated that the DGKθ mRNA was
expressed in abundance throughout the developmental
process, with highest expression in multiple key organs.
Thus, DGKθ may have persistent roles in diverse organs
and tissues during the embryonic stages.Conclusions
We revealed for the first time the distribution of DGKθ
during the embryonic period. These results suggest that
DGKθ may play important physiological roles not only
in the brain, but also in diverse organs and tissues dur-
ing the embryonic stages, and will serve as a basis for fu-
ture in vivo genetic, functional, and mutational analyses
of DGKθ.
Ueda et al. BMC Developmental Biology 2013, 13:35 Page 7 of 9
http://www.biomedcentral.com/1471-213X/13/35Methods
Animals
Eight-week-old mice were purchased from Nippon SLC,
Inc. (Hamamatsu, Japan). The animal works were
reviewed and approved by the Care and Use of Labora-
tory Animals of Kobe University. All procedures using
experimental animals were performed according to the
Guidelines for the Care and Use of Laboratory Animals
of Kobe University.
Immunohistochemistry
Most chemical reagents were purchased from Wako
Pure Chemical Inc. (Oosaka, Japan). C57BL/6 J mice
were anesthetized and transcardially perfused with cold
PBS(−) and fixed in 4% paraformaldehyde in PBS (−) for
10 min. Mouse embryos were isolated from pregnant
mice and fixed in 4% paraformaldehyde in PBS (−) over-
night [42]. The mouse embryos were paraffin-embedded
and sectioned at a 5 μm thickness by Kyoudoubyouri,
Inc. (Kobe, Japan) or Genostaff, Inc. (Tokyo, Japan). The
serial paraffin sections were deparaffinized in xylene,
and rehydrated using a graded series of ethanol from
99% to 50% and washed in distilled water. The sections
were then incubated in 0.03% H2O2 in PBS (−) for 1 hr,
and permeabilized with 0.3% Triton X −100 in PBS (−)
for 30 min. Subsequently, the sections were washed with
0.1% Tween 20 in PBS (−), and incubated in 0.1% Tween
20 in PBS (−) supplemented with goat serum (Dako,
Glostrup, Denmark), serving as blocking reagent, for
1 hr. Next, the sections were treated with an anti-DGKθ
antibody diluted (antibody #1, 1:50 ; antibody #2, 1:100)
in Can Get Signal immunostain solution A (Toyobo,
Tokyo, Japan) overnight. The antibodies against DGKθ,
antibody #1 (immunogen of 691–820 aa) and antibody
#2 (immunogen of 677–883 aa), were purchased from
Santa Cruz Biotechnology (California, USA), and BD
Biosciences (California, USA), respectively. The control
samples were probed with antibody that had been pre-
incubated with a DGKθ blocking polypeptide. The
bound antibodies were visualized using EnVision + Sys-
tem-HRP (Dako). The stained sections were dehydrated
using a graded series of ethanol and mounted using a
coverslip and Mount-Quick (Daido Sangyo, Gunma,
Japan). The specimens were then photographed using an
All-In-One Microscope system (BZ-8000 and BZ9000,
Keyence, Japan), as reported previously [43].
The specific blocking polypeptide of DGKθ (677–883
aa) was generated by PCR using the following prim-
ers, with pEGFP-N3-DGKθ as template: 5′-AGTCGGAT
CCGGCACAGGGAATGACCTTG-3′ and 5′-CGAGTC
ACGCTCCTCAAGTGATGAGGATCCAGTG-3′. The
amplified PCR fragment was subcloned into the pQE30
vector (Qiagen, Tokyo, Japan) for expression and purifi-
cation from E. coli.Reverse transcription–PCR analysis
Reverse transcription-PCR (RT-PCR) was performed as
described previously [44]. Briefly, organs or tissues were
dissected from 15 embryos of mice under a stereomicro-
scope and frozen immediately on dry ice. The total RNA
was isolated using a High Pure RNA Tissue Kit (Roche,
Mannheim, Germany). For each tissue, equal amounts of
RNA were reverse-transcribed with ReverTra Ace
(Toyobo). The resulting cDNA was appropriately diluted
and used to perform PCR with KOD-FX Neo (Toyobo).
The primer pair for mouse DGKθ was purchased from
Takara-Bio Inc. (Otsu, Japan) and used to amplify the
specific sequence : 5′-GGTTCAGAACAGGGCCAG
GTAG-3′ and 5′-AGGGCTGTAGGCAGGCAAAC-3′
(NCBI : NM_199011, nt.3577-3706). RT-PCR was
performed according to the manufacture′s specification.
Reactions for DGKθ were performed for 35 cycles at
98°C for 10 s, 60°C for 30 s, and 68°C for 1 min. After
electrophoretic separation, the amplified fragments were
quantified using the image-analysis software Image J.Additional files
Additional file 1: Figure S1. Conformation of DGKθ expression
patterns by in situ hybridization and western blotting. (A) High-
magnification images showing the cardiac end of the stomach, and
dorsal skin at E17.5. Epithelium (ep), dorsal skin (ds). (B) Sagittal
sections showing the DGKθ mRNA expression by in situ hybridization
analysis at E17.5. In situ hybridization were subjected to general
method with digoxigenin (DIG)-labeled RNA antisense probe and
visualized by anti-DIG antibody conjugated with alkaline phosphatase
and the substrate NBT/BCIP (Roche). The specific probe (541–967 bp:
the length 427 bp) were generated by DIG RNA Labeling kit [T7 RNA
polymerase] using purified mouse DGKθ PCR product (541–967 bp:
the length 427 bp) which produced by the following primers and
mouse whole brain cDNA library : 5’-AGGGAGGGGAACCTGCCTTC-3’
and 5’-GATCGAATTCTAATACGACTCACTATAGGGCCTCATTCCGA
GCCAGGCGGG-3’. The deparaffinized sections were incubated for
16 hr at 42°C in 4 × SSC containing 40% formamide, 0.1 × Denhardt’s
solution, 10 mM DTT, and DIG-labeled RNA antisense probe
(1 μg/ml). After hybridization, the sections were washed twice for
15 min at 37°C with 2 × SSC and subsequently washed twice for
5 min at 37°C with 0.4 × SSC. (C) Estimation of the specificity of the
anti-DGKθ antibodies. Adult mouse heart and whole brain were lysed
in RIPA buffer containing protease inhibitor cocktails (Nacalai tesque).
Total cell lysate (30 μg protein) was applied to SDS-polyacrylamide
gel electrophoresis (7.5%) and subjected to western blotting with
anti-DGKθ antibody diluted (antibody #1, 1:100; antibody #2, 1:200) in
Can Get Signal solution (Toyobo). The numbers on the right margin
represent the molecular sizes of the pre-stained protein standard.
Additional file 2: Figure S2. Specificity of the anti-DGKθ antibody against
DGKθ and other DGKs. EGFP-fused DGKθ [45] and DGKβ [13] were transiently
expressed in HeLa cells and cultured for 24 hr. The cells were fixed with 4%
paraformaldehyde in PBS (−) and permeabilized with 0.3% Triton X −100 in PBS
(−). Immunofluorescence staining was performed using the indicated
antibodies followed by usual method [46]. Scale bar, 20 μm.
Additional file 3: Figure S3. Expression patterns of DGKθ at E17.5. (A)
High-magnification images showing the area of the renal medulla at
E17.5. Collecting tubule (ct), Bowman’s capsule (bc). (B-H) Sagittal sections
showing the staining pattern of anti-DGKθ antibody in abdomen and
head area. Stomach (st), pancreas (pa), kidney (ki), duodenum (du), liver
(li), neocortex (nx).
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